How a decade of pharma digitalization drove Nordic’s $8.9 bn sale of Clario to Thermo Scientific

▤ Summary

Nordic Capital sold Clario to Thermo Fisher Scientific in an $8.9 billion deal. The article links the exit to a decade of pharma digitalization that helped build Clario’s value. The transaction stands out as the largest full private equity exit globally announced last year. The focus stays on healthcare and life sciences software and services, which makes the deal relevant to software industry readers.

▦ Linked Companies